Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Hematology|November 13, 2018
Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemiaNeeraj Y Saini, Jan Cerny, Vanessa F Furtado, et al.
Cancer Genetics|December 18, 2018
Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemiaKathy Chun, Gail D Wenger, Alka Chaubey, et al.
American Journal of Hematology|February 27, 2013
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD componentsSa A Wang, Lloyd Hutchinson, Guilin Tang, et al.
American Journal of Hematology|May 20, 2026
Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP ClinicShyam A Patel, Valerie Zhu, William K Gerber, et al.
Blood Cancer Journal|June 18, 2025
Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working GroupXinyan Lu, Erica F Andersen, Rahul Banerjee, et al.
British Journal of Haematology|March 24, 2024
Natural history of clonal haematopoiesis seen in real-world haematology settingsShyam A Patel, William K Gerber, Rena Zheng, et al.
Archives of Pathology & Laboratory Medicine|July 15, 2026
Fluorescence In Situ Hybridization Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Testing Results From the College of American Pathologists/American College of Medical Genetics Cytogenetics CommitteeJess F Peterson, Guilin Tang, Christopher Mixon, et al.
Ejhaem|November 29, 2023
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptionsShyam A Patel, Jan Cerny, William K Gerber, et al.
Pageof 2